Description:

An Observational Quality of Life Study in Participants With Rheumatoid Arthritis Treated With Rituximab; ODM derived from: https://clinicaltrials.gov/show/NCT02507752

Link:

https://clinicaltrials.gov/show/NCT02507752

Keywords:
Versions (1) ▾
  1. 11/24/20
Copyright Holder:
see on clinicaltrials.gov
Uploaded on:

November 24, 2020

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY 4.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Rheumatoid Arthritis NCT02507752

Eligibility Rheumatoid Arthritis NCT02507752

Inclusion Criteria
adult participants of both genders who are 18 years or older
diagnosis of ra for at least 6 months according to the criteria of the american college of rheumatology (acr) of 1987 for the ra classification
participants with medically prescribed or being administered with unique rituximab infusion in the least 3 days, according to the approved label
ability to meet the program's requirements and to voluntarily sign the informed consent term.
Exclusion Criteria
participants who have received any investigational medication within less than or equal to (<=) 1 year before the first dose of the currently indicated treatment
participants with an active infection
participants with conditions that may interfere in the ability to understand the requests of data collection and to obey to the study's requirements
functional class iv defined based on the acr functionality criteria for ra
participants who can not or who do not want, for any reason, to answer the questionnaires.